Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 17.9K |
Gross Profit | -17.9K |
Operating Expense | 826.1K |
Operating I/L | -1,203.4K |
Other Income/Expense | 521.1K |
Interest Income | 17.3K |
Pretax | -435.8K |
Income Tax Expense | -5.0K |
Net Income/Loss | -430.8K |
Clearmind Medicine Inc. is a pre-clinical pharmaceutical company specializing in the development of novel psychedelic medicines to address unmet medical needs. Their focus lies in creating treatments for alcohol use disorders, including binge drinking, eating disorders, depression, binge eating, psychotherapy, and other mental health issues. The company's revenue model is centered around the development and commercialization of these innovative medicines to provide effective solutions for individuals struggling with various mental health and behavioral disorders.